Literature DB >> 32095201

Genetic Basis of Primary Angle Closure Glaucoma: The Role of Collagens and Extracellular Matrix.

Elahe Elahi1.   

Abstract

Entities:  

Year:  2020        PMID: 32095201      PMCID: PMC7001021          DOI: 10.18502/jovr.v15i1.5930

Source DB:  PubMed          Journal:  J Ophthalmic Vis Res        ISSN: 2008-322X


× No keyword cloud information.
Glaucoma is a heterogeneous group of optic neuropathies characterized by a specific pattern of optic nerve degeneration and visual field loss that is usually accompanied by increased intraocular pressure (IOP).[ It is a major cause of irreversible blindness worldwide.[ Primary glaucoma is classified into three major forms based on the anatomy of the anterior chamber drainage angle of the eye and the age of onset: primary congenital glaucoma (PCG), primary open angle glaucoma (POAG), and primary angle closure glaucoma (PACG).[ In glaucoma patients with increased IOP, the increase is thought to be mainly due to impaired drainage of aqueous humor from the anterior chamber.[ The etiology of all forms of glaucoma includes a genetic component as evidenced by variable prevalence in different ethnic groups, observations on familial clustering, and results of pedigree and sib-pair studies. For PCG, which is usually a monogenetic Mendelian disease, three causative genes have been identified.[ POAG and PACG are generally considered complex multifactorial disorders.[ Several POAG-causing genes have been identified, but mutations in these account for disease in less than 10% of patients.[ Compared to the other forms of glaucoma, there is much less definitive genetic data pertaining to PACG. This likely reflects the contribution of multiple genetic and perhaps environmental factors that affect various anatomical and functional features associated with PACG. PACG is an important public health entity. It is estimated that 15.7 million individuals in the world are affected with PACG. It is projected that 21 million will be affected by 2020, and that PACG by that time will cause bilateral blindness in 5.3 million people.[ Most PACG patients are from Asia, particularly China, Mongolia, Singapore, and India. Ultimately, the defining feature of PACG in individuals with glaucomatous optic nerve damage is iridocorneal angle closure. Recently, COL18A1 which encodes collagen type XVIII was identified as a gene that affects angle closure in patients of three unrelated families.[ The inheritance pattern of angle closure causing mutations in COL18A1 was autosomal dominant. It appears that mutations in this gene may cause angle closure in the fourth decade of life or later. Furthermore, COL18A1 mutations are not expected to be a common cause of angle closure-related phenotypes. The significance of having identified COL18A1 as a potential PACG-causing gene lies in emphasis on the importance of collagens and the extracellular matrix in glaucoma pathology. In pursuit of identifying genes that contribute to PACG disease, association studies and candidate gene studies have been performed and the results of these have implicated possible roles for several genes.[ However, these findings are not generally considered definitive, and putative roles of genes suggested by some studies were not confirmed in independent studies. Factors known to be associated with PACG include hyperoptic refractive error, shallow anterior chamber, thick crystalline lens, short axial length, small corneal diameter, and narrow iridocorneal angle.[ Clearly, some of these also associate with each other. In an article published in this issue of the Journal of Ophthalmic and Vision Research, the authors relied on transcriptome data pertaining to eye anterior segment tissues to select five single nucleotide polymorphisms (SNPs) whose genotypes may be associated with PACG among patients of Northeast Iran.[ Interestingly, one of the SNPs for which an association with PACG was reported is positioned in a gene (FERMT2) that encodes a component of the ECM. Results of an association study that included tens of thousands of patients and controls had also implicated the same gene with respect to PACG.[ There exists accumulating evidence that implicates various collagens specifically and the extracellular matrix more generally in the pathogenesis of glaucoma.[ Eight loci were identified in one or both of two recent large genome-wide association (GWA) studies on PACG patients, and COL11A1 that encodes one of the alpha chains of type XI collagen was one of the genes identified in both of the studies.[ An SNP in COL1A1 was associated with increased risk of myopia in Japanese and Chinese individuals.[ A GWA study of PACG in a dog breed identified COL1A2 as a susceptibility locus.[ And of course, COL18A1 was identified as a gene that affects iridocorneal angle closure in humans.[ In addition to collagens, genes with roles in the extracellular matrix and also associated with glaucoma include MMP-9, MTHFR, LTBP2, CYP1B1, and SPARC. It has been suggested that inter-individual differences in tolerance to IOP as reflected in glaucoma diagnosis with normal tension in some and ocular hypertension without glaucoma in others reflect variations in biomechanical properties of the extracellular matrix of relevant ocular tissues.[
  38 in total

1.  Collagen fibrillar network in the optic nerve head of normal monkey eyes and monkey eyes with laser-induced glaucoma--a scanning electron microscopic study.

Authors:  S Sawaguchi; B Y Yue; T Fukuchi; H Abe; K Suda; T Kaiya; K Iwata
Journal:  Curr Eye Res       Date:  1999-02       Impact factor: 2.424

2.  Anterior chamber depth in Mongolians: variation with age, sex, and method of measurement.

Authors:  P J Foster; P H Alsbirk; J Baasanhu; D Munkhbayar; D Uranchimeg; G J Johnson
Journal:  Am J Ophthalmol       Date:  1997-07       Impact factor: 5.258

3.  Biometry and primary angle-closure glaucoma among Chinese, white, and black populations.

Authors:  N G Congdon; Q Youlin; H Quigley; P T Hung; T H Wang; T C Ho; J M Tielsch
Journal:  Ophthalmology       Date:  1997-09       Impact factor: 12.079

4.  Identification of a gene that causes primary open angle glaucoma.

Authors:  E M Stone; J H Fingert; W L Alward; T D Nguyen; J R Polansky; S L Sunden; D Nishimura; A F Clark; A Nystuen; B E Nichols; D A Mackey; R Ritch; J W Kalenak; E R Craven; V C Sheffield
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

5.  Association of eNOS polymorphisms with primary angle-closure glaucoma.

Authors:  Mona S Awadalla; Suman S Thapa; Alex W Hewitt; Jamie E Craig; Kathryn P Burdon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-01       Impact factor: 4.799

6.  Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma.

Authors:  Eranga N Vithana; Chiea-Chuen Khor; Chunyan Qiao; Ningli Wang; Tin Aung; Monisha E Nongpiur; Ronnie George; Li-Jia Chen; Tan Do; Khaled Abu-Amero; Chor Kai Huang; Sancy Low; Liza-Sharmini A Tajudin; Shamira A Perera; Ching-Yu Cheng; Liang Xu; Hongyan Jia; Ching-Lin Ho; Kar Seng Sim; Ren-Yi Wu; Clement C Y Tham; Paul T K Chew; Daniel H Su; Francis T Oen; Sripriya Sarangapani; Nagaswamy Soumittra; Essam A Osman; Hon-Tym Wong; Guangxian Tang; Sujie Fan; Hailin Meng; Dao T L Huong; Hua Wang; Bo Feng; Mani Baskaran; Balekudaru Shantha; Vedam L Ramprasad; Govindasamy Kumaramanickavel; Sudha K Iyengar; Alicia C How; Kelvin Y Lee; Theru A Sivakumaran; Victor H K Yong; Serena M L Ting; Yang Li; Ya-Xing Wang; Wan-Ting Tay; Xueling Sim; Raghavan Lavanya; Belinda K Cornes; Ying-Feng Zheng; Tina T Wong; Seng-Chee Loon; Vernon K Y Yong; Naushin Waseem; Azhany Yaakub; Kee-Seng Chia; R Rand Allingham; Michael A Hauser; Dennis S C Lam; Martin L Hibberd; Shomi S Bhattacharya; Mingzhi Zhang; Yik Ying Teo; Donald T Tan; Jost B Jonas; E-Shyong Tai; Seang-Mei Saw; Do Nhu Hon; Saleh A Al-Obeidan; Jianjun Liu; Tran Nguyen Bich Chau; Cameron P Simmons; Jin-Xin Bei; Yi-Xin Zeng; Paul J Foster; Lingam Vijaya; Tien-Yin Wong; Chi-Pui Pang
Journal:  Nat Genet       Date:  2012-08-26       Impact factor: 38.330

7.  Null mutations in LTBP2 cause primary congenital glaucoma.

Authors:  Manir Ali; Martin McKibbin; Adam Booth; David A Parry; Payal Jain; S Amer Riazuddin; J Fielding Hejtmancik; Shaheen N Khan; Sabika Firasat; Mike Shires; David F Gilmour; Katherine Towns; Anna-Louise Murphy; Dimitar Azmanov; Ivailo Tournev; Sylvia Cherninkova; Hussain Jafri; Yasmin Raashid; Carmel Toomes; Jamie Craig; David A Mackey; Luba Kalaydjieva; Sheikh Riazuddin; Chris F Inglehearn
Journal:  Am J Hum Genet       Date:  2009-04-09       Impact factor: 11.025

Review 8.  Glaucoma in iran and contributions of studies in iran to the understanding of the etiology of glaucoma.

Authors:  Fatemeh Suri; Shahin Yazdani; Elahe Elahi
Journal:  J Ophthalmic Vis Res       Date:  2015 Jan-Mar

9.  Identification of genetic loci associated with primary angle-closure glaucoma in the basset hound.

Authors:  Dina F Ahram; Amy C Cook; Helga Kecova; Sinisa D Grozdanic; Markus H Kuehn
Journal:  Mol Vis       Date:  2014-04-25       Impact factor: 2.367

10.  Systematic identification of trans eQTLs as putative drivers of known disease associations.

Authors:  Harm-Jan Westra; Marjolein J Peters; Tõnu Esko; Hanieh Yaghootkar; Claudia Schurmann; Johannes Kettunen; Mark W Christiansen; Bruce M Psaty; Samuli Ripatti; Alexander Teumer; Timothy M Frayling; Andres Metspalu; Joyce B J van Meurs; Lude Franke; Benjamin P Fairfax; Katharina Schramm; Joseph E Powell; Alexandra Zhernakova; Daria V Zhernakova; Jan H Veldink; Leonard H Van den Berg; Juha Karjalainen; Sebo Withoff; André G Uitterlinden; Albert Hofman; Fernando Rivadeneira; Peter A C 't Hoen; Eva Reinmaa; Krista Fischer; Mari Nelis; Lili Milani; David Melzer; Luigi Ferrucci; Andrew B Singleton; Dena G Hernandez; Michael A Nalls; Georg Homuth; Matthias Nauck; Dörte Radke; Uwe Völker; Markus Perola; Veikko Salomaa; Jennifer Brody; Astrid Suchy-Dicey; Sina A Gharib; Daniel A Enquobahrie; Thomas Lumley; Grant W Montgomery; Seiko Makino; Holger Prokisch; Christian Herder; Michael Roden; Harald Grallert; Thomas Meitinger; Konstantin Strauch; Yang Li; Ritsert C Jansen; Peter M Visscher; Julian C Knight
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

View more
  2 in total

1.  Whole-genome sequencing unravels novel genetic determinants and regulatory pathways associated with triamcinolone acetonide-induced ocular hypertension.

Authors:  Lakshmi Badrinarayanan; Hemavathy Nagarajan; Pukhraj Rishi; Ekta Rishi; Ronnie Jacob George; Srujana Chitipothu
Journal:  Mol Genet Genomics       Date:  2022-10-12       Impact factor: 2.980

Review 2.  Pathogenesis of glaucoma: Extracellular matrix dysfunction in the trabecular meshwork-A review.

Authors:  Kate E Keller; Donna M Peters
Journal:  Clin Exp Ophthalmol       Date:  2022-01-17       Impact factor: 4.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.